Leaf Bio has completed a $40 million Series B2 financing round led by Xinfengming Group,one of the world’s leading polyester filament manufacturers, joined by Granite Asia, Guoyuan Securities, and Hefei Innovation Scitech Venture Capital, bringing the total funding to $100 million.
The new capital will accelerate the scale-up and commercial deployment of Leaf Bio’s plant-based performance material platform BioFleax®, material system ECOPEF®, and platform chemical FDCA, while strengthening its industrialization capabilities through the manufacturing expertise and industrial infrastructure of Xinfengming Group.
About Leaf Bio
Leaf Bio is a global leader in plant-based aromatic materials, dedicated to the development and production of furan-based compounds characterized by renewable sourcing, low carbon footprint, and superior performance.With proprietary technology and large-scale production capacity, including the world’s first kiloton-level facility for furan materials — Leaf Bio is advancing plant-based innovation across packaging, textiles, electronics, and mobility.
For more information, please contact:
Public Relations & Communications
press@leafbio.com